Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Excipients as stabilizers.

Crowley1

  • 1SmithKline Beecham Pharmaceuticals, New Frontiers Science Park South, Third Avenue, Harlow, UK CM19 5AW.

Pharmaceutical Science & Technology Today
|June 15, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary tuberculosis in pregnancy.

Primary care update for Ob/Gyns·2000
Same author

At-line monitoring of a submerged filamentous bacterial cultivation using near-infrared spectroscopy.

Enzyme and microbial technology·2000
Same author

Causes of climate change over the past 1000 years

Science (New York, N.Y.)·2000
Same author

Mass-independent oxygen isotope fractionation in atmospheric CO as a result of the reaction CO + OH

Science (New York, N.Y.)·1998
Same author

Local orbital forcing of antarctic climate change during the last interglacial

Science (New York, N.Y.)·1998
Same author

Strong nonlocal effects in a tokamak perturbative transport experiment.

Physical review letters·1995
Same journal

Monitor: progress and profiles.

Pharmaceutical science & technology today·2001
Same journal

Recent technological advances in oral drug delivery - a review.

Pharmaceutical science & technology today·2001
Same journal

The formulation of biopharmaceutical products.

Pharmaceutical science & technology today·2001
Same journal

Live bacterial vectors for intranasal delivery of protective antigens.

Pharmaceutical science & technology today·2001
Same journal

Computer-integrated drug design provides new leads for thromboembolic disorders.

Pharmaceutical science & technology today·2001
Same journal

The Clinical Trials Directive - a new regulatory regime for Europe?

Pharmaceutical science & technology today·2001
See all related articles

Excipients often degrade drugs, but understanding drug degradation and excipient properties allows for the stabilization of unstable active ingredients into viable pharmaceutical products.

Area of Science:

  • Pharmaceutical Science
  • Drug Delivery
  • Formulation Development

Background:

  • Excipients are commonly recognized for promoting drug degradation rather than stabilization.
  • Interactions between excipient functional groups and labile drug substances can lead to loss of molecular integrity and quality changes.
  • Research on excipients as stabilizers is limited.

Purpose of the Study:

  • To explore strategies for stabilizing unstable drug substances using excipients.
  • To leverage knowledge of drug degradation pathways and excipient characteristics for product stabilization.
  • To convert inherently unstable drugs into viable pharmaceutical products.

Main Methods:

  • Analysis of drug degradation mechanisms.
  • Characterization of excipient properties and composition.

Related Experiment Videos

  • Application of formulation strategies to enhance drug stability.

    • Main Results:

    • Identified potential for excipients to stabilize unstable drugs.
    • Demonstrated approaches to mitigate drug degradation through careful excipient selection and formulation.
    • Showcased the conversion of labile active ingredients into stable products.

    Conclusions:

    • Despite their propensity to cause degradation, excipients can be utilized as stabilizers for unstable drugs.
    • A thorough understanding of drug-excipient interactions is crucial for successful product stabilization.
    • Formulation development offers viable pathways to create stable drug products from labile substances.